A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Clinical trial NCT00249236 · COMPLETED
Trial details
- NCT number
- NCT00249236
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.